What is uric acid concentration in urine in patients with uric acid kidney stones?- a case study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F27661989%3A_____%2F25%3A10003005" target="_blank" >RIV/27661989:_____/25:10003005 - isvavai.cz</a>
Alternative codes found
RIV/70883521:28150/25:63594759
Result on the web
<a href="https://www.biochemia-medica.com/en/journal/35/3/10.11613/BM.2025.031001" target="_blank" >https://www.biochemia-medica.com/en/journal/35/3/10.11613/BM.2025.031001</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.11613/BM.2025.031001" target="_blank" >10.11613/BM.2025.031001</a>
Alternative languages
Result language
angličtina
Original language name
What is uric acid concentration in urine in patients with uric acid kidney stones?- a case study
Original language description
This case report describes a patient with uric acid kidney stones. Alkalization therapy using mainly potassium citrate is the first-choice treatment. When hyperuricosuria > 4 mmol/24 hours is present, xanthine oxidase inhibitors are added. It implies that accurate urine uric acid measurement is of high importance. Uric acid was measured in a 24-hour collection and a second-morning sample. Urine uric acid was measured after sample alkalization to pH > 6.5 and heating to 56 degrees C for 10 minutes, and for educational reasons without sample treatment. The uric acid excretion in the sample without alkalization in the 24-hour collection was 2.436 mmol, after alkalization, the excretion was 4.650 mmol/24 hours. Sample alkalization led to a prescription for xanthine oxidase inhibitor medication that is indicated as the second-line therapy when hyperuricosuria > 4 mmol/24 hours is present. This case study shows how the correct preanalytical phase is essential for medical decision-making.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30218 - General and internal medicine
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Biochemia Medica
ISSN
1330-0962
e-ISSN
1846-7482
Volume of the periodical
35
Issue of the periodical within the volume
3
Country of publishing house
HR - CROATIA
Number of pages
5
Pages from-to
nestránkováno
UT code for WoS article
001615200300006
EID of the result in the Scopus database
2-s2.0-105013687779